N
Neurogram develops an AI-driven platform that analyzes EEG data to identify neuro-biomarkers for neurological diseases, including epilepsy and Alzheimer's. This technology enhances diagnostic accuracy and reduces the time and costs associated with evaluating complex neurological conditions in critical care settings.
Updated 5 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- Neurogram develops an AI-driven platform that analyzes EEG data to identify neuro-biomarkers for neurological diseases, including epilepsy and Alzheimer's. This technology enhances diagnostic accuracy and reduces the time and costs associated with evaluating complex neurological conditions in critical care settings.